Status:
UNKNOWN
Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR
Lead Sponsor:
Neurognos
Conditions:
COVID
SARS-CoV2
Eligibility:
All Genders
18-75 years
Brief Summary
The current coronavirus disease pandemic has posed a problem and a challenge for health systems globally. In the framework of a pandemic, a diagnosis is a key tool in containing and monitoring disease...
Detailed Description
This analytical and non-interventional study will evaluate the performance of a new workflow for the detection of SARS-CoV-2 viral RNA from samples of nasopharyngeal, oropharyngeal, buccal, nasal and ...
Eligibility Criteria
Inclusion
- 18 years and older
- Volunteer able to understand and sign the informed consent
- Healthcare professionals
- Essential services company workers
Exclusion
- Older than 75 years
Key Trial Info
Start Date :
June 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 25 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04468217
Start Date
June 2 2020
End Date
September 25 2020
Last Update
July 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratorio Neurognos
Santiago, Providencia, Chile, 7500000